ACR Appropriateness Criteria® Adjuvant Therapy in Vulvar Cancer
Recommended Citation
Jolly S, Soni P, Gaffney DK, Biagioli M, Elshaikh MA, Jhingran A, Kidd E, Lee LJ, Li L, Moore DH, Rao GG, Wahl AO, Williams NL, Yashar CM, and Small W, Jr. ACR appropriateness criteria(r) adjuvant therapy in vulvar cancer. Oncology (Williston Park) 2015; 29(11):867-872.
Document Type
Article
Publication Date
11-1-2015
Publication Title
Oncology (Williston Park)
Abstract
These American College of Radiology consensus guidelines were formed from an expert panel on the appropriate use of adjuvant therapy in vulvar cancer after primary treatment with surgery. The American College of Radiology Appropriateness Criteria® are evidence-based guidelines for specific clinical conditions that are reviewed every 3 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances where evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment. The panel reviewed the pertinent literature in vulvar cancer and voted on three variants to establish appropriate use of imaging, adjuvant radiation, including dose, fields, and technique, as well as adjuvant chemotherapy. This report will aid clinicians in selecting appropriate patients for adjuvant treatment and will provide guidelines for the optimal delivery of adjuvant radiation therapy and chemotherapy.
Medical Subject Headings
Aged; Female; Humans; Lymph Nodes; Middle Aged; Neoplasm Staging; Practice Guidelines as Topic; Radiotherapy Dosage; Radiotherapy, Adjuvant; Sentinel Lymph Node Biopsy; Vulvar Neoplasms
PubMed ID
26568534
Volume
29
Issue
11
First Page
867
Last Page
872
